How We’re Mobilizing Our Resources to Help Find Solutions for Covid-19
Learn More
Share
Our SDG Commitment
At Johnson & Johnson, we aspire to profoundly change the trajectory of health for humanity. Our U.N. SDG 2020 Commitment complements our Health for Humanity 2020 Goals, which focus our citizenship and sustainability efforts where we believe Johnson & Johnson can achieve the greatest impact.
The Johnson & Johnson SDG Commitment
Johnson & Johnson was one of the first major companies to make a public commitment to the SDGs in 2016. Our SDG Commitment extends and significantly builds upon our previous U.N. Millennium Development Goals (MDG) Commitment in 2010 that improved the lives of more than 400 million women and children over the five-year time frame and furthers our long legacy of work in public health around the world.
Our commitment to dedicate our expertise, ideas and ingenuity to catalyze efforts toward achieving SDG 3 (Good Health and Well-being) SDG 5 (Gender Equality) and SDG 17 (Partnership for the Goals) reflects the Company’s unique constellation of strengths.
Our Five Focus Areas
The Johnson & Johnson SDG commitment focuses on five areas in which the Company is uniquely positioned to create sustainable and scalable impact:
Accelerating Progress Towards Our SDG Goals
More From Johnson & Johnson
Chairman & CEO Alex Gorsky shares that the company could have the first batches of a Covid-19 vaccine available for emergency-use authorization in early 2021—a substantially accelerated time frame in comparison to the typical vaccine development process.
Roland Zahn, Ph.D., a Janssen scientist and expert in viral vaccines, was at the front lines of research during the Ebola outbreak. Today he and his team are working at record speed to help deliver a potential vaccine for the novel coronavirus.
Imagine being a researcher who is staring down not only a highly infectious virus, but one that's caused the first global pandemic in more than 100 years. Meet Johnson & Johnson's Hanneke Schuitemaker, Ph.D.
